Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients
- 1 November 1989
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 87 (5), S274-S277
- https://doi.org/10.1016/0002-9343(89)90079-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patientsAntimicrobial Agents and Chemotherapy, 1989
- A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patientsJournal of Antimicrobial Chemotherapy, 1988
- Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapyAntimicrobial Agents and Chemotherapy, 1987
- Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1986
- Intravenous ciprofloxacin in the treatment of infection in immunocompromised patientsJournal of Antimicrobial Chemotherapy, 1986
- Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patientsJournal of Antimicrobial Chemotherapy, 1986
- Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumoniaAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984
- Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with GranulocytopeniaAnnals of Internal Medicine, 1982
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978